BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qu L, Deng B, Zeng Y, Cao Z. Decreased expression of the Nkx2.8 gene correlates with tumor progression and a poor prognosis in HCC cancer. Cancer Cell Int 2014;14:28. [PMID: 24678995 DOI: 10.1186/1475-2867-14-28] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Gong H, Fang L, Li Y, Du J, Zhou B, Wang X, Zhou H, Gao L, Wang K, Zhang J. miR‑873 inhibits colorectal cancer cell proliferation by targeting TRAF5 and TAB1. Oncol Rep 2018;39:1090-8. [PMID: 29328486 DOI: 10.3892/or.2018.6199] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
2 Rahman HS, Rasedee A, How CW, Zeenathul NA, Chartrand MS, Yeap SK, Abdul AB, Tan SW, Othman HH, Ajdari Z, Namvar F, Arulselvan P, Fakurazi S, Mehrbod P, Daneshvar N, Begum H. Antileukemic effect of zerumbone-loaded nanostructured lipid carrier in WEHI-3B cell-induced murine leukemia model. Int J Nanomedicine 2015;10:1649-66. [PMID: 25767386 DOI: 10.2147/IJN.S67113] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
3 Deng B, Fang J, Zhang X, Qu L, Cao Z, Wang B. Role of gelsolin in cell proliferation and invasion of human hepatocellular carcinoma cells. Gene 2015;571:292-7. [PMID: 26149653 DOI: 10.1016/j.gene.2015.06.083] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
4 Li H, Wang J, Huang K, Zhang T, Gao L, Yang S, Yi W, Niu Y, Liu H, Wang Z, Wang G, Tao K, Wang L, Cai K. Nkx2.5 Functions as a Conditional Tumor Suppressor Gene in Colorectal Cancer Cells via Acting as a Transcriptional Coactivator in p53-Mediated p21 Expression. Front Oncol 2021;11:648045. [PMID: 33869046 DOI: 10.3389/fonc.2021.648045] [Reference Citation Analysis]
5 Cao Z, Fu B, Deng B, Zeng Y, Wan X, Qu L. Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma. Cancer Cell Int 2014;14:86. [PMID: 25298747 DOI: 10.1186/s12935-014-0086-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
6 Zhu J, Wu G, Song L, Cao L, Tan Z, Tang M, Li Z, Shi D, Zhang S, Li J. NKX2-8 deletion-induced reprogramming of fatty acid metabolism confers chemoresistance in epithelial ovarian cancer. EBioMedicine 2019;43:238-52. [PMID: 31047858 DOI: 10.1016/j.ebiom.2019.04.041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
7 Chen Z, Li K, Yin X, Li H, Li Y, Zhang Q, Wang H, Qiu Y. Lower Expression of Gelsolin in Colon Cancer and Its Diagnostic Value in Colon Cancer Patients. J Cancer 2019;10:1288-96. [PMID: 30854138 DOI: 10.7150/jca.28529] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
8 Wang B, Fang J, Qu L, Cao Z, Zhou J, Deng B. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma. Tumour Biol 2015;36:6901-8. [PMID: 25851347 DOI: 10.1007/s13277-015-3377-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
9 Liu KY, Wang LT, Hsu SH, Wang SN. Homeobox Genes and Hepatocellular Carcinoma. Cancers (Basel) 2019;11:E621. [PMID: 31058850 DOI: 10.3390/cancers11050621] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]